Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts.

Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP.

J Am Acad Dermatol. 2018 Feb 10. pii: S0190-9622(18)30207-X. doi: 10.1016/j.jaad.2018.02.021. [Epub ahead of print]

2.

Case of Pediatric Bullous Systemic Lupus Erythematosus Treated with Intravenous Immunoglobulin.

Juhász M, Rogge M, Chen M, Czernik A, Jung Kim S, Geller L.

Pediatr Dermatol. 2017 Jan;34(1):e54-e56. doi: 10.1111/pde.13015. Epub 2016 Oct 25.

PMID:
27778386
3.

Paraneoplastic pemphigus: a short review.

Wieczorek M, Czernik A.

Clin Cosmet Investig Dermatol. 2016 Sep 23;9:291-295. eCollection 2016. Review.

4.

Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.

Suárez-Fariñas M, Ungar B, Noda S, Shroff A, Mansouri Y, Fuentes-Duculan J, Czernik A, Zheng X, Estrada YD, Xu H, Peng X, Shemer A, Krueger JG, Lebwohl MG, Guttman-Yassky E.

J Allergy Clin Immunol. 2015 Nov;136(5):1277-87. doi: 10.1016/j.jaci.2015.06.032. Epub 2015 Aug 24.

PMID:
26316095
5.

Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.

Czernik A.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:118-9. doi: 10.1111/cei.12535. No abstract available.

6.

Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.

Czernik A, Toosi S, Bystryn JC, Grando SA.

Autoimmunity. 2012 Feb;45(1):111-8. doi: 10.3109/08916934.2011.606452. Epub 2011 Sep 19. Review.

PMID:
21923613
7.

Paraneoplastic autoimmune multiorgan syndrome: 20 years after.

Czernik A, Camilleri M, Pittelkow MR, Grando SA.

Int J Dermatol. 2011 Aug;50(8):905-14. doi: 10.1111/j.1365-4632.2011.04868.x. Review.

PMID:
21781058
8.

The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients.

Ribbe K, Friedrichs H, Begemann M, Grube S, Papiol S, Kästner A, Gerchen MF, Ackermann V, Tarami A, Treitz A, Flögel M, Adler L, Aldenhoff JB, Becker-Emner M, Becker T, Czernik A, Dose M, Folkerts H, Freese R, Günther R, Herpertz S, Hesse D, Kruse G, Kunze H, Franz M, Löhrer F, Maier W, Mielke A, Müller-Isberner R, Oestereich C, Pajonk FG, Pollmächer T, Schneider U, Schwarz HJ, Kröner-Herwig B, Havemann-Reinecke U, Frahm J, Stühmer W, Falkai P, Brose N, Nave KA, Ehrenreich H.

BMC Psychiatry. 2010 Nov 10;10:91. doi: 10.1186/1471-244X-10-91.

9.

Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies.

Lolis M, Toosi S, Czernik A, Bystryn JC.

J Am Acad Dermatol. 2011 Mar;64(3):484-9. doi: 10.1016/j.jaad.2010.04.001. Epub 2010 Aug 7.

PMID:
20692723
10.

Kinetics of response to conventional treatment in patients with pemphigus vulgaris.

Czernik A, Bystryn JC.

Arch Dermatol. 2008 May;144(5):682-3. doi: 10.1001/archderm.144.5.682. No abstract available.

PMID:
18490602
11.
12.

Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus.

Czernik A, Beutner EH, Bystryn JC.

J Am Acad Dermatol. 2008 May;58(5):796-801. doi: 10.1016/j.jaad.2008.01.007.

PMID:
18423257
13.

Does imiquimod work in infantile hemangiomas?

Czernik A, Bystryn JC.

J Am Acad Dermatol. 2007 Sep;57(3):535; author reply 536. No abstract available.

PMID:
17707162
14.

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin.

Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S, Heinz G, Erdag S, Jahn H, Degner D, Ritzen M, Mohr A, Wagner M, Schneider U, Bohn M, Huber M, Czernik A, Pollmächer T, Maier W, Sirén AL, Klosterkötter J, Falkai P, Rüther E, Aldenhoff JB, Krampe H.

Mol Psychiatry. 2007 Feb;12(2):206-20. Epub 2006 Oct 10.

PMID:
17033631
15.

Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.

Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P.

Psychopharmacology (Berl). 2005 Oct;181(4):751-60. Epub 2005 Sep 29.

PMID:
15988572
16.

Multislice spiral computed tomographic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography?

Haberl R, Tittus J, Böhme E, Czernik A, Richartz BM, Buck J, Steinbigler P.

Am Heart J. 2005 Jun;149(6):1112-9.

PMID:
15976796
17.

Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.

Nikisch G, Agren H, Eap CB, Czernik A, Baumann P, Mathé AA.

Int J Neuropsychopharmacol. 2005 Sep;8(3):403-10. Epub 2005 Mar 23.

PMID:
15784158
18.

Structural domains involved in the regulation of transmitter release by synapsins.

Hilfiker S, Benfenati F, Doussau F, Nairn AC, Czernik AJ, Augustine GJ, Greengard P.

J Neurosci. 2005 Mar 9;25(10):2658-69.

19.

Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.

Nikisch G, Mathé AA, Czernik A, Eap CB, Jiménez-Vasquez P, Brawand-Amey M, Baumann P.

J Clin Psychopharmacol. 2004 Jun;24(3):283-90.

PMID:
15118482
20.

Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression.

Pukrop R, Schlaak V, Möller-Leimkühler AM, Albus M, Czernik A, Klosterkötter J, Möller HJ.

Psychiatry Res. 2003 Jul 15;119(1-2):63-79.

PMID:
12860361
21.

[Invasive versus noninvasive (MSCT) coronary angiography. Importance of cardiac diagnostics with multislice computed tomography].

Böhme E, Steinbigler P, Czernik A, Luber A, Scherzberg-Doktorczyk A, Buck J, Haberl R.

Herz. 2003 Feb;28(1):36-43. German.

PMID:
12616319
22.

[Personality and personality disorders II. The Specificity of the DAPP-model as a diagnostic system for personality disorders].

Steinmeyer EM, Klosterkötter J, Möller HJ, Sass H, Herpertz S, Czernik A, Marcea JT, Matakas F, Mehne J, Bottländer H, Hesse W, Steinbring I, Pukrop R.

Fortschr Neurol Psychiatr. 2002 Dec;70(12):641-6. Review. German.

PMID:
12459945
23.

[Personality and personality disorders I. Universality and sensitivity of dimensional personality models as diagnostic systems for personality disorders].

Steinmeyer EM, Klosterkötter J, Möller HJ, Sass H, Herpertz S, Czernik A, Marcea JT, Matakas F, Mehne J, Bottländer H, Hesse W, Steinbring I, Pukrop R.

Fortschr Neurol Psychiatr. 2002 Dec;70(12):630-40. Review. German.

PMID:
12459944
24.

Spatial and temporal regulation of Ca2+/calmodulin-dependent protein kinase II activity in developing neurons.

Menegon A, Verderio C, Leoni C, Benfenati F, Czernik AJ, Greengard P, Matteoli M, Valtorta F.

J Neurosci. 2002 Aug 15;22(16):7016-26.

25.

A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth.

Kao HT, Song HJ, Porton B, Ming GL, Hoh J, Abraham M, Czernik AJ, Pieribone VA, Poo MM, Greengard P.

Nat Neurosci. 2002 May;5(5):431-7.

PMID:
11976703
26.

[Personality, accentuated traits and personality disorders. A contribution to dimensional diagnosis of personality disorders].

Pukrop R, Steinmeyer EM, Woschnik M, Czernik A, Matthies H, Sass H, Klosterkötter J.

Nervenarzt. 2002 Mar;73(3):247-54. German.

PMID:
11963260
27.

Bidirectional changes in synapsin I phosphorylation at MAP kinase-dependent sites by acute neuronal excitation in vivo.

Yamagata Y, Jovanovic JN, Czernik AJ, Greengard P, Obata K.

J Neurochem. 2002 Mar;80(5):835-42.

28.

Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON.

Jaffrey SR, Benfenati F, Snowman AM, Czernik AJ, Snyder SH.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3199-204. Epub 2002 Feb 26.

29.

Opposing changes in phosphorylation of specific sites in synapsin I during Ca2+-dependent glutamate release in isolated nerve terminals.

Jovanovic JN, Sihra TS, Nairn AC, Hemmings HC Jr, Greengard P, Czernik AJ.

J Neurosci. 2001 Oct 15;21(20):7944-53.

30.

ARPP-16/ARPP-19: a highly conserved family of cAMP-regulated phosphoproteins.

Dulubova I, Horiuchi A, Snyder GL, Girault JA, Czernik AJ, Shao L, Ramabhadran R, Greengard P, Nairn AC.

J Neurochem. 2001 Apr;77(1):229-38.

31.

Phosphorylation of protein phosphatase inhibitor-1 by Cdk5.

Bibb JA, Nishi A, O'Callaghan JP, Ule J, Lan M, Snyder GL, Horiuchi A, Saito T, Hisanaga S, Czernik AJ, Nairn AC, Greengard P.

J Biol Chem. 2001 Apr 27;276(17):14490-7. Epub 2001 Jan 29.

32.

Tonically active protein kinase A regulates neurotransmitter release at the squid giant synapse.

Hilfiker S, Czernik AJ, Greengard P, Augustine GJ.

J Physiol. 2001 Feb 15;531(Pt 1):141-6.

33.

Identification of synapsin I peptides that insert into lipid membranes.

Cheetham JJ, Hilfiker S, Benfenati F, Weber T, Greengard P, Czernik AJ.

Biochem J. 2001 Feb 15;354(Pt 1):57-66.

34.

Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.

Ho L, Guo Y, Spielman L, Petrescu O, Haroutunian V, Purohit D, Czernik A, Yemul S, Aisen PS, Mohs R, Pasinetti GM.

Neurosci Lett. 2001 Feb 9;298(3):191-4.

PMID:
11165439
35.

Stimulation of unitary T-type Ca(2+) channel currents by calmodulin-dependent protein kinase II.

Barrett PQ, Lu HK, Colbran R, Czernik A, Pancrazio JJ.

Am J Physiol Cell Physiol. 2000 Dec;279(6):C1694-703.

36.

Use of phosphosynapsin I-specific antibodies for image analysis of signal transduction in single nerve terminals.

Menegon A, Dunlap DD, Castano F, Benfenati F, Czernik AJ, Greengard P, Valtorta F.

J Cell Sci. 2000 Oct;113 ( Pt 20):3573-82.

37.

Synapsins as mediators of BDNF-enhanced neurotransmitter release.

Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS.

Nat Neurosci. 2000 Apr;3(4):323-9.

PMID:
10725920
38.

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC Jr, Nairn AC, Greengard P.

Nature. 1999 Dec 9;402(6762):669-71.

PMID:
10604473
39.

Identification of the putative mammalian orthologue of Sec31P, a component of the COPII coat.

Shugrue CA, Kolen ER, Peters H, Czernik A, Kaiser C, Matovcik L, Hubbard AL, Gorelick F.

J Cell Sci. 1999 Dec;112 ( Pt 24):4547-56.

40.

Synapsins as major neuronal Ca2+/S100A1-interacting proteins.

Heierhorst J, Mitchelhill KI, Mann RJ, Tiganis T, Czernik AJ, Greengard P, Kemp BE.

Biochem J. 1999 Dec 1;344 Pt 2:577-83.

41.

Regulation of synaptotagmin I phosphorylation by multiple protein kinases.

Hilfiker S, Pieribone VA, Nordstedt C, Greengard P, Czernik AJ.

J Neurochem. 1999 Sep;73(3):921-32.

42.

Phylogenetically conserved CK-II phosphorylation site of the murine homeodomain protein Hoxb-6.

Fienberg AA, Nordstedt C, Belting HG, Czernik AJ, Nairn AC, Gandy S, Greengard P, Ruddle FH.

J Exp Zool. 1999 Apr 15;285(1):76-84.

PMID:
10327653
43.

Phosphorylation of the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein at Ser655 by a novel protein kinase.

Isohara T, Horiuchi A, Watanabe T, Ando K, Czernik AJ, Uno I, Greengard P, Nairn AC, Suzuki T.

Biochem Biophys Res Commun. 1999 May 10;258(2):300-5.

PMID:
10329382
44.

Synapsins as regulators of neurotransmitter release.

Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ, Greengard P.

Philos Trans R Soc Lond B Biol Sci. 1999 Feb 28;354(1381):269-79. Review.

45.

Two sites of action for synapsin domain E in regulating neurotransmitter release.

Hilfiker S, Schweizer FE, Kao HT, Czernik AJ, Greengard P, Augustine GJ.

Nat Neurosci. 1998 May;1(1):29-35. Erratum in: Nat Neurosci 1998 Aug;1(4):329.

PMID:
10195105
46.

[Quality of life. Construct validation and the development of a modular system].

Pukrop R, Möller HJ, Sass H, Sauer H, Klosterkötter J, Czernik A, Krausz M, Stieglitz RD, Lambert M, Matthies H, Schaub A, Woschnik M, Wulfinghoff F, Steinmeyer EM.

Nervenarzt. 1999 Jan;70(1):41-53. German.

PMID:
10087517
47.

Ca2+/calmodulin-dependent kinase II mediates simultaneous enhancement of gap-junctional conductance and glutamatergic transmission.

Pereda AE, Bell TD, Chang BH, Czernik AJ, Nairn AC, Soderling TR, Faber DS.

Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13272-7.

48.

A third member of the synapsin gene family.

Kao HT, Porton B, Czernik AJ, Feng J, Yiu G, Häring M, Benfenati F, Greengard P.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4667-72.

49.
50.

Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade.

Desdouits-Magnen J, Desdouits F, Takeda S, Syu LJ, Saltiel AR, Buxbaum JD, Czernik AJ, Nairn AC, Greengard P.

J Neurochem. 1998 Feb;70(2):524-30.

Supplemental Content

Loading ...
Support Center